ArticleBMC bioinformatics2010
Multi-task learning for cross-platform siRNA efficacy prediction: an in-silico study.
Article in BMC bioinformatics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 77 citations in OpenAlex.
- Multi-Platform Multivariate Regression with Group Sparsity for High-Dimensional Data Integration.Entropy (Basel, Switzerland) · 2026Article
- Multi-task learning with a natural metric for quantitative structure activity relationship learning.Journal of cheminformatics · 2019Article
- Knowledge-transfer learning for prediction of matrix metalloprotease substrate-cleavage sites.Scientific reports · 2017Article
- When drug discovery meets web search: Learning to Rank for ligand-based virtual screening.Journal of cheminformatics · 2015Article
- An ensemble method approach to investigate kinase-specific phosphorylation sites.International journal of nanomedicine · 2014Article
- VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses.Journal of translational medicine · 2013Article
- Using multitask classification methods to investigate the kinase-specific phosphorylation sites.Proteome science · 2012Article
- In silico target-specific siRNA design based on domain transfer in heterogeneous data.PloS one · 2012Article
- DSIR: assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes.PloS one · 2012Article
- Reconsideration of in-silico siRNA design based on feature selection: a cross-platform data integration perspective.PloS one · 2012Article
- Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study.BMC bioinformatics · 2011Article
- Bevasiranib for the treatment of wet, age-related macular degeneration.Ophthalmology and eye diseases · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGene silencing using exogenous small interfering RNAs (siRNAs) is now a widespread molecular tool for gene functional study and new-drug target identification. The key mechanism in this technique is to design efficient siRNAs that incorporated into the RNA-induced silencing complexes (RISC) to bind and interact with the mRNA targets to repress their translations to proteins. Although considerable progress has been made in the computational analysis of siRNA binding efficacy, few joint analysis of different RNAi experiments conducted under different experimental scenarios has been done in research so far, while the joint analysis is an important issue in cross-platform siRNA efficacy prediction. A collective analysis of RNAi mechanisms for different datasets and experimental conditions can often provide new clues on the design of potent siRNAs.
resultsAn elegant multi-task learning paradigm for cross-platform siRNA efficacy prediction is proposed. Experimental studies were performed on a large dataset of siRNA sequences which encompass several RNAi experiments recently conducted by different research groups. By using our multi-task learning method, the synergy among different experiments is exploited and an efficient multi-task predictor for siRNA efficacy prediction is obtained. The 19 most popular biological features for siRNA according to their jointly importance in multi-task learning were ranked. Furthermore, the hypothesis is validated out that the siRNA binding efficacy on different messenger RNAs(mRNAs) have different conditional distribution, thus the multi-task learning can be conducted by viewing tasks at an "mRNA"-level rather than at the "experiment"-level. Such distribution diversity derived from siRNAs bound to different mRNAs help indicate that the properties of target mRNA have important implications on the siRNA binding efficacy.
conclusionsThe knowledge gained from our study provides useful insights on how to analyze various cross-platform RNAi data for uncovering of their complex mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.